Life Sciences

Politics look set to trump patents in China’s coronavirus vaccine effort

Remarks made by Xi Jinping suggest that if a Chinese company develops a covid-19 cure, compulsory licensing’s big moment might not arrive after all

Politics look set to trump patents in China’s coronavirus vaccine effort
CRISPR patent war flares up again at the PTAB
28 May 2020

CRISPR patent war flares up again at the PTAB

Uncertainty continues to hinder the Cas9 IP landscape as US dispute enters its next phase

European Patent Office still top for quality and service, new <em>IAM</em> benchmarking report finds
27 May 2020

European Patent Office still top for quality and service, new IAM benchmarking report finds

Top ratings once again for the agency led by António Campinos, but Andrei Iancu’s USPTO slips down, according to respondents to our annual survey of in-house and private practice professionals

Latest

View all
26 May 2020

Revealed: the billions to be spent on patent renewals in 2021 and beyond

Samsung on the hook for over $135 million this year alone, with China's national IP office and the USPTO set to pull in $100 billion over lifetime of all their active grants Read more

26 May 2020

WHO covid-19 IP pool launches this week without strong pharma support

Open and global sharing of patents, data and know-how is seen as a step too far by many life sciences innovators Read more

25 May 2020

Japanese covid-19 patent pledge triples membership, but users must read fine print

Big-name electronics and chemical companies have continued to sign on, but several have taken the opportunity to narrow the terms of the pledge and remind potential infringers that they won’t tolerate abuse Read more

23 May 2020

The coronavirus has ended all hope of US patent eligibility reform

Opponents of stronger laws have seized the opportunity created by the pandemic to build a narrative that will make legislative changes to the 101 regime almost impossible to secure Read more

News

View all
22 May 2020

Iancu on new USPTO licensing platform – “IP will play critically important role in fighting pandemic”

The agency's Patents 4 Partnerships initiative is designed to help rights owners make relevant assets available in fight against covid-19 Read more

21 May 2020

Global calls for compulsory covid-19 patent licensing build

Scrutiny of biopharma innovators’ coronavirus IP strategies will continue to intensify in coming months as concerns mount about access to treatments Read more

18 May 2020

PGR decision provides much-needed clarity in fast-growing microbiome space

First post-grant decision in the technology sector nevertheless gives some hope to gut bacteria innovators, despite invalidating a key cancer treatment patent Read more

15 May 2020

Patent owners should prepare for further PTAB changes

From key case law to radical new ways of working, four leading experts share their predictions about what might happen next at the board Read more

Analysis

View all
20 May 2020

IBM, LG and Nokia among top patent sellers in bumper Q1 for deals

Intellectual Ventures divestments continue to dominate the market while other NPEs seek to bolster their portfolios Read more

19 May 2020

Huawei, Facebook, Capital One and Walmart see huge jumps in patent filings

New data from IPO points to some big-name players restocking their portfolios as economic crisis looms Read more

19 May 2020

Top 50 PCT representative firms revealed

Japan’s Shiga International Patent Office is number one on the list, with Fish & Richardson and Epping Hermann Fischer leading for the US and Europe respectively Read more

19 May 2020

EPO plant patent change after president’s intervention raises major concerns

The enlarged board’s decision that plants produced by biological processes are unpatentable has shocked the IP profession and came after office head António Campinos asked it to look again at previous ruling Read more

Insights

View all
4 Mar 2020

IP market news highlights

A rundown of some of the top news stories on the IAM platform in December, January and February. Read more

29 Nov 2019

IP market news highlights

IAM’s biggest autumn reads Read more

24 May 2019

IP market news highlights

Some of the major news stories carried on the IAM platform from March to mid-May. Read more

1 Apr 2019

IP market news highlights

The big stories from the IAM platform in February and March. Read more